HUM - Humana Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
280.94
+2.53 (+0.91%)
As of 11:19AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close278.41
Open279.60
Bid281.48 x 900
Ask281.71 x 1000
Day's Range279.35 - 282.26
52 Week Range225.65 - 355.88
Volume349,039
Avg. Volume1,076,657
Market Cap38.686B
Beta (3Y Monthly)1.09
PE Ratio (TTM)15.35
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.20 (0.79%)
Ex-Dividend Date2019-09-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cigna Expands Health Care Exchange Offerings to New Markets
    Zacks

    Cigna Expands Health Care Exchange Offerings to New Markets

    Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.

  • Ten quotes from Humana Co-founder David Jones Sr. that are worth repeating
    American City Business Journals

    Ten quotes from Humana Co-founder David Jones Sr. that are worth repeating

    The Humana co-founder had a way with words. Here's some of our favorite quotes through the years.

  • Humana and Seniorlink to Serve Medicare Advantage Members
    Zacks

    Humana and Seniorlink to Serve Medicare Advantage Members

    Humana (HUM) collaborates with Seniorlink to unveil Virtual Care Team pilot for offering its Medicare Advantage members an improved healthcare management.

  • David Jones Sr., who built a health insurance juggernaut in Louisville, dies at 88
    American City Business Journals

    David Jones Sr., who built a health insurance juggernaut in Louisville, dies at 88

    Humana Inc. co-founder David Jones Sr. has died at the age of 88, according to the company. Jones, originally from the California neighborhood in Louisville's West End, has been one of the city's most influential business leaders for decades. Betty Jones, David's wife, passed away about a month ago, on August 16 at the age of 86.

  • Strategic Acquisitions Aid Revenue Growth at Ensign Group
    Zacks

    Strategic Acquisitions Aid Revenue Growth at Ensign Group

    Ensign Group's (ENSG) series of strategic buyouts aids its top line and the trend is expected to continue.

  • Buyers Return to Health Care Plan Stocks
    Investopedia

    Buyers Return to Health Care Plan Stocks

    Here's why managed health care stocks could outperform the S&P 500 into year end. Trade three industry leaders using these strategies.

  • Here's How Cigna (CI) is Poised Amid Political Uncertainty
    Zacks

    Here's How Cigna (CI) is Poised Amid Political Uncertainty

    Growth in health services, government business and international markets drive Cigna's (CI) stock.

  • Why Should You Retain Centene (CNC) Stock in Your Portfolio?
    Zacks

    Why Should You Retain Centene (CNC) Stock in Your Portfolio?

    Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.

  • Is Humana (HUM) a Great Value Stock Right Now?
    Zacks

    Is Humana (HUM) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Dow Surpasses 27,000 on Friday
    GuruFocus.com

    Dow Surpasses 27,000 on Friday

    Broadcom reports 3rd-quarter results Continue reading...

  • Powerful CEO council to establish investment fund
    American City Business Journals

    Powerful CEO council to establish investment fund

    The Louisville Healthcare CEO Council is taking major steps forward with a new strategic plan and a new chairman.  The group is made up of 10 of the area's most prominent health care CEOs. Joe Steier, a member of the council and CEO of long-term-care provider Signature Healthcare Inc., will lead the development of the investment fund in partnership with an already-established capital investment committee which is led by Michael Bryant, the chief operating officer of senior Trilogy Health Service Inc., a senior care and housing provider.  The innovation center will be overseen by William Altman, former chief strategy officer for Kindred Healthcare.

  • Barrons.com

    Health-Care Stocks Are Worth a Look Despite Worry Over Price Regulation, Analyst Says

    The sector has lagged behind the broader market, partly because of concern that the government could act to rein in drug prices.

  • Why Should You Retain WellCare Health in Your Portfolio?
    Zacks

    Why Should You Retain WellCare Health in Your Portfolio?

    Riding on increasing membership and inorganic growth strategies, WellCare Health (WCG) holds potential to reap benefits for investors. Besides, the company inks a merger deal with Centene in 2020.

  • Humana (HUM) Ties Up to Boost Medicare Advantage Network
    Zacks

    Humana (HUM) Ties Up to Boost Medicare Advantage Network

    Humana (HUM) collaborates with Iora Health to strengthen its Medicare Advantage network across Texas, Georgia and Arizona.

  • Humana grows national health care presence with primary care clinics
    American City Business Journals

    Humana grows national health care presence with primary care clinics

    Humana's venture with a Boston-based primary care provider has expanded access to specialized primary care clinics.

  • GuruFocus.com

    Wall Street Green on Wednesday

    Navistar jumps on strong quarterly results Continue reading...

  • Why you could see a Saint Thomas doctor or nurse without leaving your couch
    American City Business Journals

    Why you could see a Saint Thomas doctor or nurse without leaving your couch

    The partnership is the first of its kind for Ascension, which operates 151 hospitals across the country.

  • Humana Ties Up to Enhance Facilities for Members in Michigan
    Zacks

    Humana Ties Up to Enhance Facilities for Members in Michigan

    Humana (HUM) teams up with McLaren Physician Partners to provide in-network access to its members in Michigan.

  • How a health care 'hedge fund' run by ex-congressman plans to cut costs
    Yahoo Finance

    How a health care 'hedge fund' run by ex-congressman plans to cut costs

    The Healthcare Transformation Alliance, led by former N.J. Congressman Rob Andrews, has saved its members at least $400 million in overall health care spending.

  • Hedge Funds Pile Into Health Care
    Investopedia

    Hedge Funds Pile Into Health Care

    Hedge funds continue to rotate out of tech stocks and into health care despite increased regulatory threats to the sector.

  • How Companies Spent Their Summer Vacation: Selling Bonds
    Bloomberg

    How Companies Spent Their Summer Vacation: Selling Bonds

    (Bloomberg Opinion) -- By all accounts, it was supposed to be a sleepy August for the U.S. corporate bond market. Three weeks ago, the thinking went something like this: Sure, the Federal Reserve would cut its benchmark lending rate on July 31, in what Chair Jerome Powell would call a “mid-cycle adjustment.” But Treasuries were already pricing in such a move on the short end. Further out on the curve, the 30-year yield was about 2.6%, still more than 50 basis points away from its all-time low. Ten-year yields were about 2%, which seemed like a comfortable range for both buyers and sellers. For company finance officers, it had the makings of a sellers’ market but one that would be around once summer drew to a close.Then things got crazy. The 30-year yield lurched lower by 8 basis points on Aug. 1, then 13 basis points on Aug. 5, then another 13 basis points on Aug. 12. After a one-day reprieve near its all-time low of 2.0882%, it cruised through that level, tumbling to as low as 1.914%. The rally was so intense that the U.S. Treasury Department made an unusual, unscheduled announcement that it was again exploring issuing 50- or 100-year bonds. Companies clearly felt they couldn’t afford to pass up this opportunity. In the first full week of August, CVS Health Corp., Humana Inc. and Welltower Inc. headlined $35 billion of debt sales among investment-grade firms, easily surpassing estimates. Then in the week through Aug. 16, more than $22 billion went through, including a rarely seen offering from Exxon Mobil to the tune of $7 billion. Market watchers expected that would just about wrap things up until after Labor Day on Sept. 2.Some finance officers had other ideas. 3M Co. borrowed $3.25 billion on Monday to help finance its acquisition of medical-products maker Acelity Inc. In total, issuers sold $6.65 billion of investment-grade debt on Aug. 19, already topping some predictions for $5 billion this week. Then on Tuesday, Bank of New York Mellon Corp. priced $1 billion at the lower end of its expected yield range, along with a handful of other borrowers with multimillion-dollar deals.All this is to say, companies are simple: They see staggering low yields, and they issue bonds. Investors, for their part, can’t get enough of them. The Bloomberg Barclays U.S. Corporate Bond Index has returned 13.3% so far in 2019. Over the past 12 months, the index is up 12.5%, compared with just 1.5% for the S&P 500 Index. The average spread on corporate bonds has widened to 122 basis points, from 107 basis points at the end of July, but that’s just because they couldn’t keep up with the relentless rally in Treasuries, not because of a lack of buyers.  If Bank of America Corp. strategists led by Hans Mikkelsen are correct, the demand in credit markets has lasting power. They say the $16 trillion of negative-yielding debt globally has left investors — and particularly those outside the U.S. — with few alternatives besides purchasing companies’ debt. “There is a wall of new money being forced into the global corporate bond market,” they wrote on Aug. 16. “Given the near extinction of non-USD IG yield, foreign investors are forced to take more risk.”Of course, buying investment-grade bonds hardly qualifies as a speculative endeavor. Exxon Mobil, in fact, has the same credit rating as the U.S. government from both Moody’s Investors Service and S&P Global Ratings. On the other hand, Bloomberg News’s Jeannine Amodeo and Davide Scigliuzzo reported this week that three leveraged-loan sales that had been languishing in the U.S. market for weeks were pulled as investors sought higher-quality assets. Vewd Software became the fourth on Tuesday, scrapping a $125 million term loan due to market conditions. Leveraged loans, it should be noted, are floating-rate securities and so face weaker demand when the Fed appears poised to cut rates, as it does now. But for large, highly rated companies, their behavior in recent weeks is exactly what should be expected. Exxon Mobil issued 30-year bonds to yield 3.095%. In November, five-year Treasuries offered the same amount. 3M, rated a few steps below triple-A, priced 30-year debt to yield 3.37%, less than the going rate on long Treasury bonds just nine months ago. No matter how you slice it, they’re getting borrowing costs that seemed unthinkable around this time last year.Interestingly, these low yields should be encouraging governments to borrow more, too. I wrote last week that the bond markets were begging for infrastructure spending. However, it seems neither Germany nor the U.S. has any appetite for that sort of initiative. The German government is reportedly preparing fiscal stimulus that could be triggered by a deep recession, while President Donald Trump hasn’t ruled out a payroll tax cut to stave off any economic weakness.It’s certainly possible that U.S. yields will only fall further from here, and other companies can also borrow or refinance at rock-bottom interest rates. But the move in global bond markets in recent weeks could was extreme, to say the least. The weak demand for Germany’s 30-year bond auction on Wednesday, which offered a coupon of 0% at a yield of -0.11%, suggests there are at least some lines that investors won’t cross.For prudent companies, it was well worth delaying summer vacations to get their deals done.To contact the author of this story: Brian Chappatta at bchappatta1@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brian Chappatta is a Bloomberg Opinion columnist covering debt markets. He previously covered bonds for Bloomberg News. He is also a CFA charterholder.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Three state attorneys general challenge Trump on immigrant benefits
    Yahoo Finance

    Three state attorneys general challenge Trump on immigrant benefits

    The health care ecosystem could see the clock turn back on improvements to costs due the public charge rule.

  • Should Value Investors Consider Humana (HUM) Stock Now?
    Zacks

    Should Value Investors Consider Humana (HUM) Stock Now?

    Let's see if Humana (HUM) stock is a good choice for value-oriented investors right now from multiple angles.

  • David Tepper Invests in 2 Managed Care Companies in 2nd Quarter
    GuruFocus.com

    David Tepper Invests in 2 Managed Care Companies in 2nd Quarter

    Guru also buys satellite telecom company Continue reading...

  • Health insurers to expand ACA offerings
    Yahoo Finance Video

    Health insurers to expand ACA offerings

    In 2019, insurance companies will be widening their Affordable Care Act plan offerings, expanding their roster of states to places like Pennsylvania, Georgia, and Nebraska, where the options have been limited. Yahoo Finance's Anjalee Khemlani joins The First Trade to discuss.